PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments

Figure 2

[¹⁸F]Fluciclatide PET: (a) patient with lung and pleural metastases. (b) Intralesion heterogeneity of uptake within pleural metastasis in PET image, which was not demonstrated as necrosis on corresponding CT section. (c) Liver metastases imaged as hypointense lesions because of high background signal (high uptake in spleen is possibly due to blood pooling) (with permission from Kenny et al. [18]).

(a)

(b)

(c)